These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 25335196)
1. The Federal Circuit's decision in Myriad: isolated DNA molecules are patentable subject matter. Ogden SR Am Univ Law Rev; 2011; 61(2):443-56. PubMed ID: 25335196 [No Abstract] [Full Text] [Related]
2. Who owns human genes?: Is DNA patentable? Gostin LO JAMA; 2013 Aug; 310(8):791-2. PubMed ID: 23877839 [No Abstract] [Full Text] [Related]
3. Intellectual property. Supreme Court rules out patents on 'natural' genes. Marshall E Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772 [No Abstract] [Full Text] [Related]
4. US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes. Dyer C BMJ; 2012 Oct; 345():e6624. PubMed ID: 23033368 [No Abstract] [Full Text] [Related]
5. US Supreme Court hears arguments in case of BRCA1 and BRCA2 [corrected] patents. McCarthy M BMJ; 2013 Apr; 346():f2446. PubMed ID: 23596230 [No Abstract] [Full Text] [Related]
7. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid. Dyer C BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689 [No Abstract] [Full Text] [Related]
8. After the Myriad decision: do hurdles remain for diagnostics competition? Waller PR; Young DW MLO Med Lab Obs; 2013 Sep; 45(9):46. PubMed ID: 24147337 [No Abstract] [Full Text] [Related]
9. Supreme Court to Myriad Genetics: Synthetic DNA is Patentable but Isolated Genes Are Not. Weinmeyer R; Klusty T AMA J Ethics; 2015 Sep; 17(9):849-53. PubMed ID: 26390207 [No Abstract] [Full Text] [Related]
10. A little light on the Mayo: justifying reversal of the Federal Circuit's Association for Molecular Pathology decision. Georgek KJ Seton Hall Law Rev; 2014; 44(1):171-206. PubMed ID: 24654292 [No Abstract] [Full Text] [Related]
11. The Supremes got it right. Somberg J Am J Ther; 2013; 20(4):315. PubMed ID: 23838630 [No Abstract] [Full Text] [Related]
12. Data disclosure crucial after DNA patent verdict. de Costa A Science; 2013 Aug; 341(6149):959. PubMed ID: 23990544 [No Abstract] [Full Text] [Related]
14. Our shared code: the Myriad decision and the future of genetic research. Levy S Environ Health Perspect; 2013 Aug; 121(8):A250-3. PubMed ID: 23907093 [No Abstract] [Full Text] [Related]
15. BRCA patent dispute may head to US Supreme Court. Devi S Lancet; 2012 Jan; 379(9813):300. PubMed ID: 22292161 [No Abstract] [Full Text] [Related]
17. Are human genes patentable? Cook-Deegan R Ann Intern Med; 2013 Aug; 159(4):298-9. PubMed ID: 23752709 [No Abstract] [Full Text] [Related]
18. Intellectual property. In a flurry of metaphors, justices debate a limit on gene patents. Marshall E Science; 2013 Apr; 340(6131):421. PubMed ID: 23620028 [No Abstract] [Full Text] [Related]
19. Patenting genes: what does Association for Molecular Pathology v. Myriad Genetics mean for genetic testing and research? Cartwright-Smith L Public Health Rep; 2014 May; 129(3):289-92. PubMed ID: 24790252 [No Abstract] [Full Text] [Related]
20. Patent law. Law and science collide over human gene patents. Cook-Deegan R Science; 2012 Nov; 338(6108):745-7. PubMed ID: 23139317 [No Abstract] [Full Text] [Related] [Next] [New Search]